with lupus nephritis than in young MRL/mice with normal kidneys (14) and treatment of NZB/W mice with IL-1 accelerates the onset of lupus nephritis (15). Finally treatment of MRL/mice with Bay11-7082 an NFκB inhibitor with an unbiased inhibitory influence on the INCB024360 NLRP3 inflammasome decreases lupus nephritis (19) and anakinra (IL-1 receptor antagonist) could be… Continue reading with lupus nephritis than in young MRL/mice with normal kidneys (14)